Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07469241) titled 'Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Fudan University
Condition:
Advanced Esophageal Squamous Cell Carcinoma
Unresectable Esophageal Squamous Cell Carcinoma
Intervention:
Combination Product: Concurrent chemoradiotherapy (cCRT)
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: March 10, 2026
Target Sample Size: 50 ...